Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial
Open Access
- 1 June 2005
- journal article
- clinical trial
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (11), 4160-4167
- https://doi.org/10.1158/1078-0432.ccr-05-0120
Abstract
Purpose: To investigate the safety and the immunologic and clinical responses of dendritic cell therapy for patients with recurrent malignant glioma.Keywords
This publication has 31 references indexed in Scilit:
- Sequential delivery of interferon-α gene and DCs to intracranial gliomas promotes an effective antitumor responseGene Therapy, 2004
- Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant GliomaCancer Research, 2004
- Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2Melanoma Research, 2003
- Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate–pulsed dendritic cellsBlood, 2003
- 7-Hydroxystaurosporine-induced Apoptosis in 9L Glioma Cells Provides an Effective Antigen Source for Dendritic Cells and Yields a Potent Vaccine Strategy in an Intracranial Glioma ModelNeurosurgery, 2002
- Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki Forest virus—mediated complementary DNAJournal of Neurosurgery, 2001
- Treatment of intracranial gliomas with bone marrow—derived dendritic cells pulsed with tumor antigensJournal of Neurosurgery, 1999
- Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cellsNature Medicine, 1996
- Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo.The Journal of Experimental Medicine, 1993
- Intratumoral injection of OK432 and lymphokine-activated killer activity in peripheral blood of patients with hepatocellular carcinomaEuropean Journal of Cancer and Clinical Oncology, 1990